24 May 2013
Keywords: fda, approval, news, brief, rhone-poulenc, rorer, received
Article | 02 April 1998
Rhone-Poulenc Rorer has received approval to market DDAVP tablets(desmopressin acetate) in the USA for the treatment of primary nocturnal
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com